AR101

Aimmune Presents New Peanut Allergy Data and Presses for Real-World Data Approaches
BioSpace
Sat, 11/9/19 - 12:07 pm
Aimmune Therapeutics
peanut allergy
AR101
real world data
RWE
No surprises in FDA staff review for Aimmune peanut allergy therapy — focus remains on safety, tolerability profile
Endpoints
Wed, 09/11/19 - 10:27 am
Aimmune
FDA
peanut allergy
Palforzia
AR101
New peanut allergy therapies aren’t as effective — or nearly as inexpensive — as abstinence, says ICER
Endpoints
Thu, 07/11/19 - 12:03 pm
peanut allergy
Aimmune Therapeutics
DBV Technologies
ICER
AR101
Viaskin Peanut
FDA schedules Aimmune's peanut allergy drug for September expert review
Biopharma Dive
Thu, 05/16/19 - 12:01 pm
Aimmune Therapeutics
peanut allergy
FDA
AR101
4 Blockbuster Drug Launches to Watch in 2019
Motley Fool
Sun, 03/24/19 - 08:08 pm
drug launches
AbbVie
Alexion Pharmaceuticals
Aimmune Therapeutics
Skyrizi
psoriasis
Upadacitinib
rheumatoid arthritis
Ultomiris
PNH
AR101
peanut allergy
Aimmune has its answer on peanut drug's status, but how FDA proceeds still unclear
BioSpace
Fri, 03/1/19 - 08:30 pm
Aimmune Therapeutics
peanut allergy
FDA
AR101
Aimmune says shutdown blocks peanut allergy drug review
Fierce Biotech
Tue, 01/15/19 - 09:53 am
Aimmune Therapeutics
peanut allergy
AR101
FDA
government shutdown
Aimmune's peanut allergy treatment could 'change practice' — with safety challenges and a price anything but peanuts
Endpoints
Mon, 11/19/18 - 09:51 am
Aimmune Therapeutics
AR101
peanut allergy
Peanut allergy therapy scores trial win, putting it in line to possibly become first protective treatment
Stat
Tue, 02/20/18 - 09:24 am
peanut allergy
food allergies
clinical trials
AR101
Aimmune
Aimmune's peanut allergy drug clears Phase II on the way to a pivotal test
Fierce Biotech
Tue, 03/8/16 - 10:12 am
Aimmune
peanut allergy
AR101
clinical trials